Equities

Apollo Hospitals Enterprise Ltd

  • Add to watchlist
  • Add to portfolio
  • Add an alert
APOLLOHOSP:NSI

Apollo Hospitals Enterprise Ltd

Actions
Health CareHealth Care Providers
  • Price (INR)7,647.50
  • Today's Change71.00 / 0.94%
  • Shares traded385.97k
  • 1 Year change+20.28%
  • Beta0.7801
Data delayed at least 15 minutes, as of Feb 18 2026 10:15 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Apollo Hospitals Enterprise Limited is an integrated healthcare company. It is engaged in the business of providing hospital services and selling pharma and wellness products through a network of pharmacies, including the operation of multidisciplinary private hospitals, clinics, diagnostic centers and pharmacies. It is engaged in hospitals and hospitals-based services. The Company's segments include Healthcare Services, Retail Health and Diagnostics, Digital Health and Pharmacy Distribution, and Others. Retail Health and Diagnostics segment includes clinics and diagnostics. Digital Health and Pharmacy Distribution segment is engaged in the business of procurement and distribution of pharmaceuticals, fast-moving consumer goods and private label products business from various services using the digital platform. The Company has approximately 10,000 plus beds across 73 hospitals, 5000 plus pharmacies and 378 plus clinics and diagnostic centers, as well as 200 telemedicine centers.

  • Revenue in INR (TTM)242.15bn
  • Net income in INR18.02bn
  • Incorporated1979
  • Employees42.50k
  • Location
    Apollo Hospitals Enterprise Ltd"Ali Towers" Ill Floor, #55, Greams RoadCHENNAI 600006IndiaIND
  • Phone+91 4 428290956
  • Fax+91 4 428290956
  • Websitehttps://www.apollohospitals.com/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
APOLLOHOSP:NSI since
announced
Transaction
value
Apollo Gleneagles PET-CT Pvt LtdDeal completed12 Aug 202512 Aug 2025Deal completed5.51%970.00k
Data delayed at least 15 minutes, as of Feb 18 2026 10:15 GMT.

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Dr. Lal PathLabs Ltd26.63bn5.28bn240.27bn4.98k45.42--34.999.0231.6831.68159.67--------5,346,978.00--15.99--20.0180.5876.8720.0216.80--28.16--17.4010.5413.0936.1716.61-7.5114.87
Krishna Institute Of Medical Sciencs Ltd36.27bn3.01bn284.08bn5.26k94.61--50.217.837.507.5090.50--------6,890,198.00--12.25--14.9979.5154.488.6815.55--3.61--0.0021.4922.0123.9726.4080.97--
Global Health Ltd41.82bn5.14bn314.95bn10.26k61.31--43.807.5319.1219.12155.68--------4,076,368.00--8.40--9.7676.9576.2312.2811.38--10.09----12.7419.730.678267.6728.04--
Aster DM Healthcare Ltd44.61bn3.27bn323.55bn15.29k97.71--51.707.256.416.4187.43--------2,917,520.00--2.22--3.7654.9958.298.054.98--3.66----11.88-13.71150.512.08-7.64--
Narayana Hrudayalaya Ltd66.78bn7.79bn371.49bn11.41k47.64--32.185.5638.4038.41329.60--------5,851,870.00--12.09--15.4264.7647.3511.6611.85--5.53--9.7712.1211.880.47346.0256.3335.10
Fortis Healthcare Ltd87.70bn9.60bn684.86bn12.24k71.34--48.557.8112.7212.72116.20--------7,167,094.00--4.60--5.8276.8272.8811.199.18--5.51--9.3912.9110.9329.2867.9540.28--
Max Healthcare Institute Ltd81.40bn14.19bn1.05tn15.11k74.07--56.8212.8614.5314.5383.36--------5,385,934.00--7.55--8.4978.3876.9117.4315.91--7.71----30.0130.121.7262.3761.19--
Apollo Hospitals Enterprise Ltd242.15bn18.02bn1.09tn42.50k60.65--40.734.51125.33125.331,684.28--------5,698,097.00--6.28--8.2947.9648.067.525.46--5.99--21.3114.3514.1560.9126.0327.2725.93
Data as of Feb 18 2026. Currency figures normalised to Apollo Hospitals Enterprise Ltd's reporting currency: Indian Rupee INR

Institutional shareholders

17.48%Per cent of shares held by top holders
HolderShares% Held
The Vanguard Group, Inc.as of 04 Feb 20263.87m2.69%
Mirae Asset Investment Managers (India) Pvt Ltd.as of 31 Jan 20263.15m2.19%
BlackRock Fund Advisorsas of 06 Feb 20262.86m1.99%
Axis Asset Management Co. Ltd.as of 31 Jan 20262.72m1.89%
SBI Funds Management Ltd.as of 31 Jan 20262.58m1.79%
Aditya Birla Sun Life Amc Ltd. (Investment Management)as of 31 Jan 20262.21m1.54%
Schroder Investment Management (Hong Kong) Ltd.as of 31 Dec 20252.12m1.48%
Norges Bank Investment Managementas of 31 Dec 20251.95m1.35%
Nippon Life India Asset Management Ltd. (Invt Mgmt)as of 05 Feb 20261.92m1.33%
ICICI Prudential Asset Management Co. Ltd. (Invt Mgmt)as of 31 Jan 20261.77m1.23%
More ▼
Data from 31 Dec 2025 - 10 Feb 2026Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.